Position in PAHC
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,716,386
+$1,072,263 QoQ
Shares Held
54,662
+217.0% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#48
of 207 holders
Holding Since
Dec 2023
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $54,645,005 across 16 Drug Manufacturers - Specialty & Generic names. PAHC ranks #10 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
147,055 | $10,567,372 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
14,271 | $7,732,455 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
190,145 | $6,592,327 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
136,725 | $5,609,826 | |
| 5 | VTRS |
Viatris Inc
|
331,130 | $5,258,344 | |
| 6 | PRGO |
PERRIGO Co plc
|
346,586 | $3,601,028 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
411,346 | $3,257,860 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
34,505 | $2,856,323 |
All Filings in PAHC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,716,386 | 54,662 | Shares | Sole | 2026-07-14 | |
| 2025-12-31 | $644,123 | 17,241 | Shares | Sole | 2026-02-13 | |
| 2023-12-31 | $173,537 | 14,986 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||